Correlation Between Summit Therapeutics and 04686E2Y7

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and 04686E2Y7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and 04686E2Y7 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and ATH 25 24 MAR 28, you can compare the effects of market volatilities on Summit Therapeutics and 04686E2Y7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of 04686E2Y7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and 04686E2Y7.

Diversification Opportunities for Summit Therapeutics and 04686E2Y7

-0.57

Correlation Coefficient

Summit Therapeutics  04686E2Y7

Excellent diversification

The 3 months correlation between Summit and 04686E2Y7 is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and ATH 25 24 MAR 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATH 25 24 and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with 04686E2Y7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATH 25 24 has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and 04686E2Y7 go up and down completely randomly.

Pair Corralation between Summit Therapeutics and 04686E2Y7

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.24 times more return on investment than 04686E2Y7. However, Summit Therapeutics is 1.24 times more volatile than ATH 25 24 MAR 28. It trades about -0.07 of its potential returns per unit of risk. ATH 25 24 MAR 28 is currently generating about -0.14 per unit of risk. If you would invest  2,177  in Summit Therapeutics PLC on October 11, 2024 and sell it today you would lose (295.00) from holding Summit Therapeutics PLC or give up 13.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	17.07%
Values	Daily Returns

Summit Therapeutics PLC  vs.  ATH 25 24 MAR 28

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

ATH 25 24

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ATH 25 24 MAR 28 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for ATH 25 24 MAR 28 investors.

Pair Trading with Summit Therapeutics and 04686E2Y7

The main advantage of trading using opposite Summit Therapeutics and 04686E2Y7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, 04686E2Y7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 04686E2Y7 will offset losses from the drop in 04686E2Y7's long position.

The idea behind Summit Therapeutics PLC and ATH 25 24 MAR 28 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.